EirGenix (ROCO:6589) Change In Other Working Capital : NT$-100 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is EirGenix Change In Other Working Capital?

EirGenix's Change In Other Working Capital for the quarter that ended in Mar. 2024 was NT$-87 Mil. It means EirGenix's Other Working Capital declined by NT$87 Mil from Dec. 2023 to Mar. 2024 .

EirGenix's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was NT$-154 Mil. It means EirGenix's Other Working Capital declined by NT$154 Mil from Dec. 2022 to Dec. 2023 .

EirGenix Change In Other Working Capital Historical Data

The historical data trend for EirGenix's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix Change In Other Working Capital Chart

EirGenix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

347.75

110.92

-25.21

-9.77

-154.27

EirGenix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															-142.01	-55.48	-2.21	45.43	-87.30

EirGenix Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-100 Mil.

EirGenix Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of EirGenix's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

EirGenix (ROCO:6589) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180

Website

https://www.eirgenix.com

EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.

EirGenix (ROCO:6589) Headlines

No Headlines